Delivery Order SPE2DB22D9225-SPE2DB25FR8FL
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,456.01 by the Defense Logistics Agency (DLA) on August 13, 2025. The contract calls for the delivery of Cosentyx Unoready 300 mg pen 2ml pharmaceutical product to a location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,382.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $70,817.80 by the Defense Logistics Agency's Medical Supply Chain division on August 11, 2025. This delivery order, with an ultimate completion date of August 18, 2025, is issued under the company's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,661.78 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a task order issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,116.58 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order represents a discrete purchase of pharmaceutical products under the company's larger indefinite delivery contract with the Defense Logistics Agency, which is valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $37,693.80 by the Defense Logistics Agency's Medical Supply Chain division on August 13, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, carries no set-aside designation and represents performance at the contractor's Park Ridge location. The award leverages DMS Pharmaceutical Group's position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $242,935.80 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain division. This delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain. The award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,311.35 on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, is issued without a set-aside designation and represents work performed at the contractor's Park Ridge, Illinois location. The award falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $10,818.64 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a direct purchase of pharmaceutical products for defense healthcare operations. The award carries no set-aside designation, allowing the...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order from the Defense Logistics Agency (DLA), a defense agency, for the supply of COSENTYX UNOREADY 300 MG PEN 2ML. The contract has a firm fixed price of $39,295.74 and a completion date of June 18, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
- SPE2DB22D9225Indefinite Delivery Contract
- SPE2DB22D9225-SPE2DB25FR8FLDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 18, 2025, for Cosentyx Unoready 300 mg pen 2 ml pharmaceutical products. The contract is valued at $16,800.32 under a firm fixed-price arrangement with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation, leveraging the contractor's competitive positioning within the federal pharmaceutical supply market. Performance will be executed at the contractor's facility in Park Ridge, Illinois. This award represents a continuation of DMS Pharmaceutical Group's substantial role as a critical supplier within the federal pharmaceutical supply chain. The delivery order was issued under the company's significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC framework enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables supporting the medical supply needs of Department of Defense healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.8k | 8/18/25 |